Phase 2 Human Papilloma Virus Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
Oropharyngeal CancerThroat CancerHuman Papilloma Virus+2 more
Memorial Sloan Kettering Cancer Center121 enrolled7 locationsNCT05491512
Recruiting
Phase 2
Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV Vaccination
Human Papilloma Virus Infection Type 16
Universiteit Antwerpen50 enrolled3 locationsNCT07407569
Recruiting
Phase 1Phase 2
TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers
Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell CarcinomaHuman Papilloma Virus+1 more
University of Chicago98 enrolled1 locationNCT05108870
Recruiting
Phase 2
Candida Antigen and Bivalent HPV Vaccine in the Treatment of Multiple Warts
Human Papilloma VirusWarts
Zagazig University162 enrolled1 locationNCT05291845
Recruiting
Phase 2
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
Human Papilloma VirusAnal DysplasiaHIV
University of Maryland, Baltimore120 enrolled2 locationsNCT06624839
Terminated
Phase 2
A Phase 1b, Multicentre, Open Label, Study of the Efficacy, Safety and Tolerability of R131 Ointment in Women with Cytological Abnormalities of the Uterine Cervix
cervical intraepithelial neoplasia caused by Human papilloma virus
Douglas Pharmaceuticals Ltd46 enrolled1 locationACTRN12618001726246